GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Scaled Net Operating Assets

Longevity Biomedical (Longevity Biomedical) Scaled Net Operating Assets : (As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Longevity Biomedical's operating assets for the quarter that ended in . 20 was $ Mil. Longevity Biomedical's operating liabilities for the quarter that ended in . 20 was $ Mil. Longevity Biomedical's Total Assets for the quarter that ended in . 20 was $ Mil. Therefore, Longevity Biomedical's scaled net operating assets (SNOA) for the quarter that ended in . 20 was .


Longevity Biomedical Scaled Net Operating Assets Historical Data

The historical data trend for Longevity Biomedical's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Scaled Net Operating Assets Chart

Longevity Biomedical Annual Data
Trend
Scaled Net Operating Assets

Longevity Biomedical Semi-Annual Data
Scaled Net Operating Assets

Competitive Comparison of Longevity Biomedical's Scaled Net Operating Assets

For the Biotechnology subindustry, Longevity Biomedical's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longevity Biomedical's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Scaled Net Operating Assets falls into.



Longevity Biomedical Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Longevity Biomedical's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in . 20 is calculated as

Scaled Net Operating Assets (SNOA)(A: . 20 )
=(Operating Assets (A: . 20 )-Operating Liabilities (A: . 20 ))/Total Assets (A: . 20 )
=(-)/
=

where

Operating Assets(A: . 20 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
= -
=

Longevity Biomedical's Scaled Net Operating Assets (SNOA) for the quarter that ended in . 20 is calculated as

Scaled Net Operating Assets (SNOA)(Q: . 20 )
=(Operating Assets (Q: . 20 )-Operating Liabilities (Q: . 20 ))/Total Assets (Q: . 20 )
=(-)/
=

where

Operating Assets(Q: . 20 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
= -
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longevity Biomedical Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Longevity Biomedical (Longevity Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines